| # | Drug | Count |
|---|---|---|
| 0 | PEMIGATINIB | 3 |
| 1 | FUTIBATINIB | 2 |
| 2 | LENVATINIB | 2 |
| 3 | CAPECITABINE | 1 |
| 4 | CISPLATIN | 1 |
| 5 | FLUOROURACIL | 1 |
| 6 | FLUOROURACIL CREAM, 0.5% | 1 |
| 7 | GEMCITABINE | 1 |
| 8 | GEMCITABINE HYDROCHLORIDE | 1 |
| 9 | NIVOLUMAB | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FUTIBATINIB | 2 | 0.0090 |
| 1 | PEMIGATINIB | 3 | 0.0035 |
| 2 | LENVATINIB | 2 | 0.0001 |
| 3 | GEMCITABINE HYDROCHLORIDE | 1 | 0.0000 |
| 4 | FLUOROURACIL CREAM, 0.5% | 1 | 0.0000 |
| 5 | FLUOROURACIL | 1 | 0.0000 |
| 6 | CISPLATIN | 1 | 0.0000 |
| 7 | CAPECITABINE | 1 | 0.0000 |
| 8 | NIVOLUMAB | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 3 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 1 |
| 2 | Platinum-based Drug [EPC] | 1 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 1 | Kinase Inhibitor [EPC] | 3 | 0.0000 |
| 2 | Platinum-based Drug [EPC] | 1 | 0.0000 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 1 | 0.0000 |